| Literature DB >> 34321868 |
Jiuling Deng1, Ying Ma2, Yuqiong He1, Shi Qiu1, Hong Yang2, Yanhong Chen2, Liang Wang1, Doudou Huang1, Xia Tao2, Wansheng Chen1.
Abstract
PURPOSE: Isatis indigotica (Ii) is a cruciferous herb that is widely distributed in China, and its roots and leaves have been used in two renowned antipyretic detoxicate crude drugs in Chinese Pharmacopoeia, Radix (R) and Folium (F) Isatidis. However, the pharmacodynamic material basis and underlying mechanisms of the herbal efficacy remained to be elucidated.Entities:
Keywords: Isatis indigotica; UPLC-Q-TOF-MS; bioassay analysis; network analysis
Mesh:
Substances:
Year: 2021 PMID: 34321868 PMCID: PMC8312626 DOI: 10.2147/DDDT.S316701
Source DB: PubMed Journal: Drug Des Devel Ther ISSN: 1177-8881 Impact factor: 4.162
Figure 1The work flow of the current study. The study aimed to propose a potential mechanism of the anti-inflammatory and anti-viral effects of Ii. A network analysis-based integrated strategy was exploited, with component identification of the herb through UPLC-Q-TOF-MS and in vitro verification.
Figure 2Identification of the main ingredients of Ii by UPLC-Q-TOF-MS. Representative TIC chromatograms of the extracts of the herbal leaves (A) and the roots (B) were presented.
17 Active Ingredients in Isatis Indigotica (Ii) Were Presented as Followed
| No. | Compounds | Acronym | CAS | Molecular Formulas | Category | GI* | DL# |
|---|---|---|---|---|---|---|---|
| 1 | Indigo | IDG | 482–89-3 | C16H10N2O2 | Indoles | High | 5 Yes† |
| 2 | Indirubin | IDR | 479–41-4 | C16H10N2O2 | Indoles | High | 5 Yes |
| 3 | Isatin | Isa | 91–56-5 | C8H5NO2 | Indoles | High | 3 Yes |
| 4 | Cephalanthrin A | Cep-A | 1829563-08-7 | C17H12N2O4 | Indoles | High | 5 Yes |
| 5 | (1H-indol-3-yl)oxoacetamide | IOA | 1380540-77-1 | C10H8N2O2 | Indoles | High | 4 Yes |
| 6 | 1-methoxy-3-indoleacetic acid | MIA | 134792-52-2 | C11H11NO3 | Indoles | High | 5 Yes |
| 7 | Secoisolariciresinol | Sec | 29388-59-8 | C20H26O6 | Lignans | High | 5 Yes |
| 8 | Secoisolariciresinol diglucoside | SDG | 158932-33-3 | C32H46O16 | Lignans | Low | 0 Yes |
| 9 | Isovitexin | Iso | 38953-85-4 | C21H20O10 | Flavonoids | Low | 1 Yes |
| 10 | 4(1H)-quinolone-3-carboxylic acid | QCA | 13721-01-2 | C10H7NO3 | Others | High | 4 Yes |
| 11 | Deoxyvasicinone | Deo | 530-53-0 | C11H10N2O | Others | High | 4 Yes |
| 12 | 2-amino-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol | AHP | 50731-36-7 | C10H15NO4 | Others | High | 4 Yes |
| 13 | Cis-coniferin | C-Con | 531-29-3 | C16H22O8 | Others | High | 4 Yes |
| 14 | 4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanoic acid | DHQ | 95494-51-2 | C12H12N2O3 | Others | High | 5 Yes |
| 15 | 2,3-dihydro-1 H-pyrrolo [2,1 -Cl [1,4] benzodiazepine-5,11 (10H, 11H) –dione] | DHP | 18877-34-4 | C12H12N2O2 | Others | High | 5 Yes |
| 16 | Corchorifatty acid B | CFA-B | 147383-02-6 | C18H28O4 | Others | High | 4 Yes |
| 17 | Indiforine A | IDF-A | 2249831-92-1 | C15H15NO7 | Others | High | 4 Yes |
Notes: *GI means gastrointestinal absorption in Pharmacokinetics analysis, obtained from SwissADME. #DL means Druglikeness analysis obtained from SwissADME, including Lipinski (Pfizer), Ghose, Veber (GSK), Egan (Pharmacia), and Muegge (Bayer) rules. †The numbers in the DL mean how many times “Yes; 0 violations” has appeared in Lipinski 5 rules.
Figure 3The structure information of 17 active compounds from Ii.
Figure 4Venn diagram of Ii and anti-inflammatory (A)/anti-viral (B). Major hubs were screened through PPI analysis for anti-inflammatory (C) and anti-viral (D) effects of the herb. A herb-active ingredient-target network was finally constructed (E).
Figure 5The top 10 related pathways to the herbal anti-inflammatory (A) and anti-viral (B) effects. Multiple-component, multi-target, and multi-pathway mechanisms of the herbal efficacy were proposed and illustrated (C).
Figure 6The cytotoxicity of the 6 ingredients was illustrated, respectively (A–F). The effects of the representative ingredients on Poly (I: C) (G–I) and LPS (J–L) treated RAW 264.7 cells were presented. Results were presented as median (min - max). n = 6; Δp<0.05, ΔΔp<0.01, ΔΔΔp<0.001 vs Control group; *p<0.05, **p<0.01, vs Poly (I: C) or LPS group.The top 10 related pathways to the herbal anti-inflammatory (A) and anti-viral (B) effects. Multiple-component, multi-target, and multi-pathway mechanisms of the herbal efficacy were proposed and illustrated (C).